P.O.R.T grant funding for Dr Adam Farmer’s EVASION-CIPO project has been announced on the University Hospitals of North Midlands website. They have celebrated our prestigious grant and highlighted the fact that rare conditions need research just as much as the common conditions do.
This year, P.O.R.T has a new research project which is expected to start in the next few months. This project is studying the impact of physiological (via deep breathing) and transcutaneous vagal nerve stimulation can reduce pain and nausea and improve small bowel motility and quality of life for patients with CIPO. You can read more about this project here.
The University Hospital of North Midlands (UHNM) has announced the P.O.R.T grant and the project on their website, saying:
“A Consultant at University Hospitals of North Midlands NHS Trust (UHNM) has been awarded a prestigious research grant to fund a study into chronic intestinal pseudo-obstruction (CIPO).”
“The study, funded by the Pseudo Obstruction Research Trust, will aim to assess whether it is possible to undertake a definitive study to evaluate whether vagus nerve stimulation will reduce pain and nausea and improve small bowel motility and quality of life in patients with CIPO.”
“Dr Adam Farmer, Consultant Gastroenterologist at UHNM and Senior Lecturer at Keele University, was awarded the grant to undertake this research at UHNM. He said: “This disorder is difficult to treat, as many of the drugs currently used to manage the symptoms of CIPO can further slow movement in the digestive system. Therefore, new treatments are urgently needed.”
“Prof Tony Fryer, R&D Director at UHNM, said: “This project provides a real opportunity to unlock a new way to treat patients with this rare condition. It illustrates the importance of research into the rarer conditions, so that as many people as possible have access to the latest technologies and treatments.”
You can read the article on the UHNM website – click here.
P.O.R.T is very excited about the project and hopes that it will lead to a new method of managing this debilitating disorder of the digestive system in the future.